医药行业分析
- (2025-09-10)
- (2025-09-10)
- (2025-09-10)
- (2025-09-10)
- (2025-09-10)
- (2025-09-10)
- (2025-09-10)
- (2025-09-10)
- (2025-09-10)
- (2025-09-10)
- (2025-09-10)
- (2025-09-10)
- (2025-09-10)
- (2025-09-09)
- (2025-09-09)
- (2025-09-09)
- (2025-09-09)
- (2025-09-09)
- (2025-09-09)
- (2025-09-09)
- (2025-09-09)
- (2025-09-09)
- (2025-09-09)
- (2025-09-09)
- (2025-09-09)
- (2025-09-09)
Nature子刊:浙大陈华钧/张强团队开发多学科AI智能体,全面集成生物学/化学/材料科学领域数百种科学工具,自动化复杂科学工作
(2025-09-09)- (2025-09-09)
- (2025-09-08)
- (2025-09-08)
- (2025-09-08)
- (2025-09-08)
- (2025-09-08)
- (2025-09-08)
- (2025-09-08)
- (2025-09-08)
- (2025-09-08)
- (2025-09-08)
- (2025-09-08)
- (2025-09-07)
- (2025-09-07)
- (2025-09-07)
- (2025-09-06)
- (2025-09-06)
- (2025-09-06)
- (2025-09-06)
- (2025-09-06)
- (2025-09-06)
- (2025-09-06)
- (2025-09-05)
- (2025-09-05)
- (2025-09-05)
- (2025-09-05)
- (2025-09-05)
- (2025-09-05)
- (2025-09-05)
《新英格兰医学杂志》与欧洲心脏病学大会同步发表循证医学结果,证实植入Firehawk®/火鹰®支架低风险心肌梗死患者实际仅需1个月双抗疗程且出血并发症可大幅减少54%
(2025-09-05)《柳叶刀》:血压控低,利大于弊!中国科学家首次大规模评估强化血压控制风险获益比,较标准降压心血管事件风险降低24%,收益超过弊端
(2025-09-05)- (2025-09-05)
- (2025-09-05)